Urology

Home Urology

Quality Improvement Collaborative Improving Cancer Screening Postpandemic

National Return-to-Screening collaborative linked to improvements in cancer screening compared with prepandemic, pandemic periods

Overactive Bladder Common in Postacute COVID-19 Syndrome

COVID-19 may lead to new or worsening urinary symptoms in men and women

Melanoma Diagnosis Linked to Increased Risk of Prostate Cancer

More than twofold increased risk of prostate cancer seen for men with first melanoma diagnosed 10 to 15 years before study recruitment

7.7 Million Deaths Associated With 33 Bacterial Pathogens in 2019

Deaths associated with these pathogens comprised 13.6 percent of all global deaths, 56.2 percent of all sepsis-related deaths

Treatment Without ADT Delays Initiation of Systemic Therapy in Prostate Cancer

Metastasis-directed therapy can delay initiation of systemic therapy in patients with solitary oligorecurrent metastatic lesion

FDA: Patients Should Be Cautious When Using Online Pharmacies to Buy Meds

Red flags include pharmacies that do not require a doctor's prescription or have a licensed pharmacist to answer questions

Cancer Mortality Up With Residential Racial, Economic Segregation

Segregation was associated with increased mortality for 12 of 13 cancer sites examined

FDA Oversight of Clinical Trials Described as ‘Grossly Inadequate’

Article describes inadequate oversight relating to development of COVID-19 vaccines and predating the pandemic

Multidimensional Factors Shaped Physician Stress During Pandemic

Physicians' perceptions of occupational stress at individual level were shaped by stressors within and across four levels

Personalized Screening for Kidney Disease Evaluated in T1DM

Compared with annual screening for urinary albumin, personalized screening can reduce time spent with undetected albuminuria, testing frequency